| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $502.3M | +3.2% |
| R&D Expense | $216.4M | +11.0% |
| SG&A Expense | $217.4M | +8.7% |
| Operating Income | -$749.4M | -363.1% |
| Pre-tax Income | -$747.6M | -366.6% |
| Income Tax | $13.6M | -27.9% |
| Net Income | -$757.5M | -331.3% |
| EPS (Basic) | -$18.02 | -331.1% |
| EPS (Diluted) | -$18.02 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $160.1M | +32.7% |
| Accounts Receivable | $64.7M | -18.6% |
| Inventory | $6.7M | +30.6% |
| Current Assets | $332.3M | +19.9% |
| Total Assets | $736.9M | -40.0% |
| Current Liabilities | $150.2M | +25.2% |
| Long-term Debt | $50.0M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.4M | -21.3% |
| Capital Expenditures | $14.2M | +59.8% |
| Investing Cash Flow | -$64.8M | -201.9% |
| Financing Cash Flow | $135.8M | +62.9% |
| Free Cash Flow | -$42.7M | -31.9% |
| -331.1% |
| Total Liabilities |
| $287.9M |
| +35.3% |
| Stockholders' Equity | $463.4M | -54.8% |